Ep 31: Re-imagining screening for serious spine pathology in practice, with IFOMPT President Laura Finucane
JOSPT Insights
00:00
How to Develop a Framework for Malignant Malignancy
There's very little evidence, if you like, about using red flag. So that was quite problematic. But there were a number of systematic reviews that we could draw on. We asked clinical experts around the world in those specific areas to tell us what e should be using within our framework and then did a consensus from expert opinion to draw those out.
Transcript
Play full episode
